To order chemicals, medical devices, or other restricted products please provide ID that includes your business name & shipping address via email [email protected] or fax 484.881.5997 referencing your VWR account number. Acceptable forms of ID are:
- • State issued document with your organization's Federal Tax ID Number
- • State issued document with your organization's Resale Tax ID Number
- • City or County issued Business License
- • State Department of Health Services License
- • Any other ID issued by the State that includes the business name & address
* ATTN: California Customers may require additional documentation as part of the CA Health & Safety Code. Products that fall under this regulation will be placed on a mandatory 21-day hold after documentation is received. Avantor will not lift restrictions for residential shipping addresses.
Specifications
- Host:
- Primary antibody reactivity:
- Description:Helicobacter pylori IgM ELISA
- Environmentally Preferable:
- Sample Type:Serum
- Application:Infectious Diseases
- Regulatory Status:FDA Regulated; CE Approved
- Cat. No.:75871-314
- Supplier no.:EIA-2111
- No. of tests:96 wells
Specifications
About this item
An enzyme immunoassay for the detection of IgM antibodies to Helicobacter pylori in serum.
- High quality assays with reproducible and reliable results
- Ready-to-use reagents with internal controls
- Very good precision and sensitivity
- Short assay time and incubation steps at room temperature
- Simple and technician friendly tests
Helicobacter pyloriis a spiral bacterium cultured from human gastric mucosa discovered by B.J. Marshall in 1982. Studies have indicated that the presence ofH. pyloriis associated with a variety of gastrointestinal diseases including gastritis, duodenal and gastric ulcers, non-ulcer dyspepsia, and gastric adenocarcinoma and lymphoma. The organism is present in 95-98% of patients with duodenal ulcers and 60-90% of patients with gastric ulcers. The studies have also demonstrated that removal of the organism by anti-microbial therapy is correlated with the resolution of symptoms and cure of diseases. Patients who present clinical symptoms relating to the gastrointestinal tract can be diagnosed forH. pyloriinfection by two methods: Invasive techniques – include biopsy followed by culture or histologic examination of biopsy specimen or direct detection of urease activity. Non-invasive techniques – include urea breath tests and serological methods. All of the testing performed on biopsy samples is subject to errors related to sampling and interference of contaminated bacteria. An ELISA test for the presence ofH. pylorispecific IgM antibody is the technique of choice for serologic tests because of its accuracy and simplicity. PurifiedH.pyloriantigen is coated on the surface of microwells. Diluted patients serum is added to the wells, and theH. pyloriIgM specific antibody, if present, binds to the antigen. All unbound materials are washed away. Enzyme conjugate is added, which binds to the antibody-antigen complex. Excess enzyme conjugate is washed off and a solution of TMB Reagent is added. The enzyme conjugate catalytic reaction is stopped at a specific time. The intensity of the color generated is proportional to the amount of IgM-specific antibody in the sample. The results are read by a microwell reader compared in a parallel manner with calibrator and controls.